Prevalence and Prognostic Value of Mediastinal Lymph Node Dissection in Pulmonary Metastasectomy: A Retrospective Single‐Center Analysis
Thoracic Cancer · 2026-04 · 17 (7)
DOI: 10.1111/1759-7714.70278 ↗Kurz gefasst
Fachartikel in der Zeitschrift Thoracic Cancer, online erschienen am 02.04.2026. Verfasst von Christian Galata und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, University Medical Center Mainz, Johannes Gutenberg University Mainz, Mainz, Germany. Hauptthemen laut MEDLINE: Lymph Node Excision, Lung Neoplasms, Metastasectomy, Mediastinum. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Pulmonary metastasectomy is an established part of the multimodal treatment of various malignant diseases. While the procedure typically focuses on complete removal of metastatic lesions, the role of mediastinal lymph node involvement remains unclear. We aimed to analyze the prevalence of lymph node involvement and its impact on prognosis in patients undergoing pulmonary metastasectomy.
Methods
Patients with different primaries with histologically confirmed pulmonary metastases that underwent pulmonary metastasectomy with the goal of complete resection were included in this retrospective analysis. The type of lymph node dissection, the type of lung resection, the number of lymph nodes harvested as well as survival data were analyzed.
Results
Among 219 patients, lymph node samples were obtained in 91 (41.6%). Lymph node metastases were identified in 13 patients (14.3%). No specific primary tumor entity showed a significantly higher risk of lymph node involvement. After a median follow‐up of 10 months, 12 of 13 lymph node positive patients (92.3%) had either radiologically confirmed active disease or had died of malignancy, compared with 47.1% in the lymph node negative group ( p = 0.013).
Conclusions
Mediastinal lymph node involvement in pulmonary metastasectomy is associated with poor prognosis and may occur across a broad spectrum of primary tumor entities. Our data may support the routine use of modern staging modalities such as PET/CT and EBUS in candidates for pulmonary metastasectomy, in order to better stratify patients and avoid unnecessary surgical interventions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Thoracic Surgery, University Medical Center Mainz, Johannes Gutenberg University Mainz, Mainz, Germany.
- University Cancer Center Mainz (UCT Mainz), University Medical Center Mainz, Johannes Gutenberg University Mainz, Mainz, Germany.
- 3rd Medical Department, University Medical Center Mainz, Johannes Gutenberg University Mainz, Mainz, Germany.
- TRON-Translational Oncology, University Medical Center, Johannes Gutenberg University Mainz, Mainz, Germany.
- German Cancer Consortium (DKTK), partner Site Frankfurt/Mainz, a Partnership Between DKFZ and University Medical Center Mainz, Mainz, Germany.
- Division of Thoracic Surgery, Evaggelismos General Hospital, Athens, Greece.
Zitieren
APA
Galata, C., Schulz, J., Grifone, L., Zapata Bonila, S. A., Kindler, T., Athanassiadi, K., Roessner, E., & Karampinis, I. (2026). Prevalence and Prognostic Value of Mediastinal Lymph Node Dissection in Pulmonary Metastasectomy: A Retrospective Single‐Center Analysis. Thoracic Cancer, 17(7). https://doi.org/10.1111/1759-7714.70278
Vancouver
Galata C, Schulz J, Grifone L, Zapata Bonila SA, Kindler T, Athanassiadi K, et al. Prevalence and Prognostic Value of Mediastinal Lymph Node Dissection in Pulmonary Metastasectomy: A Retrospective Single‐Center Analysis. Thoracic Cancer. 2026;17(7). doi:10.1111/1759-7714.70278
BibTeX
@article{Galata2026,
author = {Galata, Christian and Schulz, Jonathan and Grifone, Laura and Zapata Bonila, Sergio A and Kindler, Thomas and Athanassiadi, Kalliopi and Roessner, Eric and Karampinis, Ioannis},
title = {Prevalence and Prognostic Value of Mediastinal Lymph Node Dissection in Pulmonary Metastasectomy: A Retrospective Single‐Center Analysis},
journal = {Thoracic Cancer},
year = {2026},
volume = {17},
number = {7},
doi = {10.1111/1759-7714.70278}
}
EUVIMED